Search Results for citation:"90 FR 1130"

The Health and Human Services Department has delegated authority to the Chief of the Unaccompanied Children Bureau to make decisions related to juvenile court jurisdiction for unaccompanied alien children seeking special immigrant status. This delegation is in accordance with the William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008. It will be effective on the date of signature and conforms with existing financial, administrative, and departmental policies. The actions taken by the Chief prior to this date are also affirmed and ratified.

The Food and Drug Administration (FDA) has released a new guidance document for the industry titled “Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act.” This document establishes the conditions for compounding certain drugs and explains the FDA’s current approach while developing a list of bulk drug substances permitted for use. This guidance replaces a previous version from 2017 and provides instructions on submitting comments to the FDA. The guidance clearly states it is not legally binding but shows the FDA's current thinking on this issue.

In the Federal Register notice, there was a correction made to an earlier document published by the Health and Human Services Department and the Centers for Medicare & Medicaid Services. On December 20, 2024, a notice included a section where it indicated a placeholder date for an action deadline. This placeholder date, originally written as “[INSERT DATE 30 DAYS AFTER DATE OF PUBLICATION IN THE FEDERAL REGISTER]”, has now been updated to the specific date of January 21, 2025, to clarify the deadline.